integerafrica develops Latin American pulmonary hypertension registry - RELAHP

integerafrica is currently developing the research platform for the Latin American pulmonary hypertension registry - RELAHP

RELAHP - Registro Latinoamericano de Hipertensiòn Pulmonar - will describe the incidence, etiology and outcome of pulmonary hypertension in Latin America. The Latin American collaboration includes 12 cardiothoracic centers within the region to participate in the study. This prospective observational cohort study aims to recruit 500 patients with de novo diagnosis of pulmonary hypertension confirmed by right heart catherization who reside in Latin America. RELAHP will establish a cohort with 5 year follow-up.

RELAHP is a project of the Asociacion Latinoamericana de Tórax (ALAT) and is funded by Bayer Healthcare.

We want to thank ALAT and Bayer Healthcare for their trust in our services.